Universal Biosensors Inc (UBI) - Financial and Strategic SWOT Analysis Review

April 2021 | 40 pages | ID: U6ED5648795EN
GlobalData

Abstracts

Universal Biosensors Inc (UBI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

• Business description – A detailed description of the company’s operations and business divisions.
• Corporate strategy – Analyst’s summarization of the company’s business strategy.
• SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
• Company history – Progression of key events associated with the company.
• Major products and services – A list of major products, services and brands of the company.
• Key competitors – A list of key competitors to the company.
• Key employees – A list of the key executives of the company.
• Executive biographies – A brief summary of the executives’ employment history.
• Key operational heads – A list of personnel heading key departments/functions.
• Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
• Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
• Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Universal Biosensors Inc (UBI) is an in vitro diagnostic company which develops, designs electrochemical cell technology platform used in various industries including food and drink, healthcare and agriculture. UBI is working with Siemens Healthcare to develop a range of products for the point-of-care coagulation market and will manufacture test strips for these products. The company’s focus areas include coagulation testing, blood glucose testing and other electromechanical cell based tests. It manages its research and development, and manufacturing operations through its subsidiaries located in British Columbia, Canada and Melbourne, Australia. UBI is headquartered in Melbourne, Victoria, Australia.

Universal Biosensors Inc Key Recent Developments

Mar 17,2021: Universal Biosensors - Resignation of Director - Marshall Heinberg
Dec 30,2020: UBI’s Canadian subsidiary signs deal with Bayer AG
Nov 04,2020: UBI receives $2.8 million under the R&D Tax Incentive Rebate
Oct 19,2020: Universal Biosensors : September 2020 quarterly activity report

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

• The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

• The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

• Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.

• Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

• Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

Contents

SECTION 1 - ABOUT THE COMPANY

Universal Biosensors Inc - Key Facts
Universal Biosensors Inc - Key Employees
Universal Biosensors Inc - Key Employee Biographies
Universal Biosensors Inc - Major Products and Services
Universal Biosensors Inc - History
Universal Biosensors Inc - Company Statement
Universal Biosensors Inc - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries

SECTION 2 – COMPANY ANALYSIS

Company Overview
Universal Biosensors Inc - Business Description
Business Segment: Products Revenue
Overview
Performance
Business Segment: Service Revenue
Performance
R&D Overview
Universal Biosensors Inc - Corporate Strategy
Universal Biosensors Inc - SWOT Analysis
SWOT Analysis - Overview
Universal Biosensors Inc - Strengths
Universal Biosensors Inc - Weaknesses
Universal Biosensors Inc - Opportunities
Universal Biosensors Inc - Threats
Universal Biosensors Inc - Key Competitors

SECTION 3 – COMPANY FINANCIAL RATIOS

Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts

SECTION 4 – COMPANY’S LIFESCIENCES FINANCIAL DEALS AND ALLIANCES

Universal Biosensors Inc, Medical Equipment, Deals By Year, 2015 to YTD 2021
Universal Biosensors Inc, Medical Equipment, Deals By Type, 2015 to YTD 2021
Universal Biosensors Inc, Recent Deals Summary

SECTION 5 – COMPANY’S RECENT DEVELOPMENTS

Mar 17, 2021: Universal Biosensors - Resignation of Director - Marshall Heinberg
Dec 30, 2020: UBI’s Canadian subsidiary signs deal with Bayer AG
Nov 04, 2020: UBI receives $2.8 million under the R&D Tax Incentive Rebate
Oct 19, 2020: Universal Biosensors : September 2020 quarterly activity report

SECTION 6 – APPENDIX

Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List Of Tables

LIST OF TABLES

Universal Biosensors Inc, Key Facts
Universal Biosensors Inc, Key Employees
Universal Biosensors Inc, Key Employee Biographies
Universal Biosensors Inc, Major Products and Services
Universal Biosensors Inc, History
Universal Biosensors Inc, Subsidiaries
Universal Biosensors Inc, Key Competitors
Universal Biosensors Inc, Ratios based on current share price
Universal Biosensors Inc, Annual Ratios
Universal Biosensors Inc, Annual Ratios (Cont...1)
Universal Biosensors Inc, Annual Ratios (Cont...2)
Universal Biosensors Inc, Interim Ratios
Universal Biosensors Inc, Medical Equipment, Deals By Year, 2015 to YTD 2021
Universal Biosensors Inc, Medical Equipment, Deals By Type, 2015 to YTD 2021
Universal Biosensors Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List Of Figures

LIST OF FIGURES

Universal Biosensors Inc, Performance Chart (2016 - 2020)
Universal Biosensors Inc, Ratio Charts
Universal Biosensors Inc, Medical Equipment, Deals By Year, 2015 to YTD 2021
Universal Biosensors Inc, Medical Equipment, Deals by Type, 2015 to YTD 2021